What are the possible causes of orange urine during pregnancy and how should it be evaluated and managed?

Orange Urine During Pregnancy: Causes and Management

Orange urine in pregnancy is most commonly caused by dehydration or concentrated urine, but requires systematic evaluation to exclude urinary tract infection, liver disease, and medication effects.

Primary Causes to Consider

Dehydration and Concentrated Urine

• Concentrated urine from inadequate hydration is the most common benign cause of orange-colored urine during pregnancy 1
• Urine color correlates significantly with urine osmolality (concentration) in pregnant women, with darker colors (≥4 on standardized color charts) indicating urine osmolality ≥500 mOsm/kg 1
• Pregnant women should aim for lighter urine colors (1-3 on color charts) by increasing fluid intake 1
• Dehydration is particularly common in the context of nausea and vomiting of pregnancy or hyperemesis gravidarum 2

Urinary Tract Infection

• Asymptomatic bacteriuria occurs in pregnancy and can alter urine appearance 3, 4
• All pregnant women should be screened for bacteriuria with urine culture at least once in early pregnancy 3
• Escherichia coli is the most common causative organism 4
• Untreated bacteriuria can progress to pyelonephritis, which carries significant maternal and fetal risks 4

Liver Disease in Pregnancy

• Intrahepatic cholestasis of pregnancy presents in the second or third trimester with pruritus and can cause dark/orange urine due to elevated bilirubin 2
• Diagnosis requires serum bile acid level >10 μmol/L with mild to moderate transaminase elevations and bilirubin <6 mg/dL 2
• Other pregnancy-specific liver diseases (preeclampsia, HELLP syndrome, acute fatty liver) can also cause bilirubinuria and dark urine 2

Medications and Supplements

• Prenatal vitamins, particularly those containing riboflavin (vitamin B2) and beta-carotene, commonly cause bright orange urine
• Vitamin B6 (pyridoxine) supplementation for nausea can contribute to urine color changes 2
• Phenazopyridine (if used for urinary symptoms) causes orange urine

Evaluation Algorithm

Initial Assessment

• Obtain detailed history focusing on:
  • Fluid intake patterns and symptoms of dehydration (orthostatic symptoms, decreased skin turgor, dry mucous membranes) 2
  • Presence of pruritus suggesting cholestasis 2
  • Urinary symptoms (dysuria, frequency, urgency) suggesting infection 3, 4
  • Nausea, vomiting, or inability to maintain oral intake 2
  • Current medications and prenatal vitamin formulations
  • Gestational age (cholestasis typically occurs in second/third trimester) 2

Laboratory Workup

• Urinalysis with microscopy to assess:

  • Urine concentration/specific gravity 1
  • Presence of bilirubin (suggests liver disease) 2
  • Leukocyte esterase and nitrites (suggests infection) 3
  • Note: Microhematuria is present in up to 20% of healthy pregnancies and is not necessarily pathologic 5

• Urine culture if dipstick shows evidence of infection (≥1+ leukocyte esterase or positive nitrites) 3

• If pruritus present or liver disease suspected:

  • Serum bile acids (diagnostic threshold >10 μmol/L for cholestasis) 2
  • Liver function tests (AST, ALT, bilirubin, alkaline phosphatase) 2
  • Note: Mild alkaline phosphatase elevation is physiologic in second/third trimester 2

Management Based on Etiology

Dehydration/Concentrated Urine

• Increase oral fluid intake with goal of achieving lighter urine color (1-3 on color chart) 1
• If associated with hyperemesis gravidarum requiring hospitalization, initiate IV hydration and antiemetic therapy 2
• Thiamine 100 mg daily for minimum 7 days if severe nausea/vomiting to prevent Wernicke encephalopathy 2

Confirmed Urinary Tract Infection

• Treat with 3-7 days of appropriate antibiotics (nitrofurantoin, cephalexin, or sulfisoxazole preferred; avoid ampicillin due to resistance) 3, 4
• Perform periodic screening for recurrent bacteriuria following treatment 3

Intrahepatic Cholestasis of Pregnancy

• Initiate ursodeoxycholic acid 10-15 mg/kg/day in divided doses 2
• Monitor serum bile acids to guide timing of delivery:
  • Bile acids >100 μmol/L: deliver at 36 weeks or at diagnosis if after 36 weeks 2
  • Bile acids <100 μmol/L: deliver at 36-39 weeks depending on when diagnosed 2
  • Bile acids <40 μmol/L: consider delivery at term 2

Medication-Related

• Reassure patient if due to prenatal vitamins or B-complex supplements (benign finding)
• Consider alternative vitamin formulation if patient finds color change distressing

Critical Pitfalls to Avoid

• Do not dismiss orange urine as solely vitamin-related without excluding infection and liver disease, particularly if accompanied by pruritus or systemic symptoms 2, 3
• Do not use ketonuria as an indicator of dehydration severity in pregnancy, as it is not reliably associated with hydration status 6
• Do not delay evaluation of suspected cholestasis, as bile acid levels >100 μmol/L significantly increase risk of stillbirth after 35 weeks 2
• Physiologic hydronephrosis occurs in >80% of pregnant women in second/third trimester, so hydronephrosis on imaging does not necessarily indicate obstruction or infection 7